Literature DB >> 17108028

Structure-based identification of a major neutralizing site in an adenovirus hexon.

Susan L Pichla-Gollon1, Mark Drinker, Xiangyang Zhou, Feng Xue, John J Rux, Guang-Ping Gao, James M Wilson, Hildegund C J Ertl, Roger M Burnett, Jeffrey M Bergelson.   

Abstract

Virus-specific neutralizing antibodies present an obstacle to the effective use of adenovirus vectors for gene therapy and vaccination. The specific sites recognized by neutralizing antibodies have not been identified for any adenovirus, but they have been proposed to reside within the hexon, in small regions of the molecule that are exposed on the capsid surface and possess sequences that vary among serotypes. We have mapped the epitopes recognized by a panel of seven hexon-specific monoclonal antibodies that neutralize the chimpanzee adenovirus 68 (AdC68). Surface plasmon resonance experiments revealed that the antibodies compete for a single hexon binding site, and experiments with synthetic peptides indicated that this site resides within just one small surface loop. Mutations within this loop (but not in other surface loops) permitted virus to escape neutralization by all seven monoclonal antibodies and to resist neutralization by polyclonal antisera obtained from animals immunized against AdC68. These results indicate that a single small surface loop defines a major neutralization site for AdC68 hexon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108028      PMCID: PMC1797575          DOI: 10.1128/JVI.02023-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.

Authors:  C I Toogood; J Crompton; R T Hay
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

2.  Electrophoretic migration of adenovirus hexon under non-denaturing conditions.

Authors:  E Fortsas; M Petric; M Brown
Journal:  Virus Res       Date:  1994-01       Impact factor: 3.303

3.  SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Authors:  N Guex; M C Peitsch
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

4.  Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest.

Authors:  A N Warrens; M D Jones; R I Lechler
Journal:  Gene       Date:  1997-02-20       Impact factor: 3.688

5.  Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Authors:  H Gahéry-Ségard; F Farace; D Godfrin; J Gaston; R Lengagne; T Tursz; P Boulanger; J G Guillet
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.

Authors:  C A Mack; W R Song; H Carpenter; T J Wickham; I Kovesdi; B G Harvey; C J Magovern; O W Isom; T Rosengart; E Falck-Pedersen; N R Hackett; R G Crystal; A Mastrangeli
Journal:  Hum Gene Ther       Date:  1997-01-01       Impact factor: 5.695

7.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.

Authors:  A Mastrangeli; B G Harvey; J Yao; G Wolff; I Kovesdi; R G Crystal; E Falck-Pedersen
Journal:  Hum Gene Ther       Date:  1996-01       Impact factor: 5.695

9.  The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 A resolution.

Authors:  F K Athappilly; R Murali; J J Rux; Z Cai; R M Burnett
Journal:  J Mol Biol       Date:  1994-09-30       Impact factor: 5.469

10.  Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy.

Authors:  P L Stewart; S D Fuller; R M Burnett
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  43 in total

1.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

2.  Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Authors:  Susan L Pichla-Gollon; Shih-Wen Lin; Scott E Hensley; Marcio O Lasaro; Larissa Herkenhoff-Haut; Mark Drinker; Nia Tatsis; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Jeffrey M Bergelson
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

3.  Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.

Authors:  Maxime J J Fleury; Antoine Touzé; Marie-Christine Maurel; Thierry Moreau; Pierre Coursaget
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

4.  Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.

Authors:  Dongming Zhou; Te-Lang Wu; Kristel L Emmer; Raj Kurupati; Steven Tuyishime; Yan Li; Wynetta Giles-Davis; Xiangyang Zhou; Zhiquan Xiang; Qin Liu; Sarah J Ratcliffe; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2012-12-11       Impact factor: 11.454

5.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

6.  Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.

Authors:  Hongling Qiu; Xiao Li; Xingui Tian; Zhichao Zhou; Ke Xing; Haitao Li; Ni Tang; Wenkuan Liu; Peisheng Bai; Rong Zhou
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

7.  Interaction of Human Enterochromaffin Cells with Human Enteric Adenovirus 41 Leads to Serotonin Release and Subsequent Activation of Enteric Glia Cells.

Authors:  Sonja Westerberg; Marie Hagbom; Anandi Rajan; Vesa Loitto; B David Persson; Annika Allard; Johan Nordgren; Sumit Sharma; Karl-Eric Magnusson; Niklas Arnberg; Lennart Svensson
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

8.  Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.

Authors:  Takayuki Shiratsuchi; Urvashi Rai; Anja Krause; Stefan Worgall; Moriya Tsuji
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

9.  Molecular evolution of human adenovirus type 16 through multiple recombination events.

Authors:  Xingui Tian; Hongkai Wu; Rong Zhou
Journal:  Virus Genes       Date:  2019-08-05       Impact factor: 2.332

Review 10.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.